These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25762713)

  • 61. The ethics of cluster-randomized trials requires further evaluation: a refinement of the Ottawa Statement.
    van der Graaf R; Koffijberg H; Grobbee DE; de Hoop E; Moons KG; van Thiel GJ; de Wit GA; van Delden JJ
    J Clin Epidemiol; 2015 Sep; 68(9):1108-14. PubMed ID: 25910909
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.
    Goldstein CE; Weijer C; Brehaut JC; Fergusson DA; Grimshaw JM; Horn AR; Taljaard M
    BMC Med Ethics; 2018 Feb; 19(1):14. PubMed ID: 29482537
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Informed consent, capitation, and conflicts of interest in clinical trials: views from the field.
    Angelos P; Murphy TF; Sampson H; Hollings DD; Kshettry V
    Surgery; 2006 Nov; 140(5):740-8. PubMed ID: 17084716
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Deep Brain Stimulation for Alzheimer's Disease: Ethical Challenges for Clinical Research.
    Siegel AM; Barrett MS; Bhati MT
    J Alzheimers Dis; 2017; 56(2):429-439. PubMed ID: 27983548
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Self-experimentation.
    Davis JK
    Account Res; 2003; 10(3):175-87. PubMed ID: 14979319
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Informed consent for dementia research: the study enrollment encounter.
    Black BS; Kass NE; Fogarty LA; Rabins PV
    IRB; 2007; 29(4):7-14. PubMed ID: 17847621
    [No Abstract]   [Full Text] [Related]  

  • 67. Informed consent on trial.
    Cressey D
    Nature; 2012 Jan; 482(7383):16. PubMed ID: 22297946
    [No Abstract]   [Full Text] [Related]  

  • 68. An ethical analysis of exception from informed consent regulations.
    Morris MC
    Acad Emerg Med; 2005 Nov; 12(11):1113-9. PubMed ID: 16264082
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Secret randomised clinical trials.
    Lancet; 1982 Jul; 2(8289):78-9. PubMed ID: 6123813
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Variability in IRBs regarding parental acceptance of passive consent.
    Higgerson RA; Olsho LE; Christie LM; Rehder K; Doksum T; Gedeit R; Giuliano JS; Brennan B; Wendlandt R; Randolph AG;
    Pediatrics; 2014 Aug; 134(2):e496-503. PubMed ID: 25002659
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Government-scripted consent: when medical ethics and law collide.
    Minkoff H; Marshall MF
    Hastings Cent Rep; 2009; 39(5):21-3. PubMed ID: 19806776
    [No Abstract]   [Full Text] [Related]  

  • 72. Assessing Parent Decisions About Child Participation in a Behavioral Health Intervention Study and Utility of Informed Consent Forms.
    Kraft SA; Porter KM; Duenas DM; Sullivan E; Rowland M; Saelens BE; Wilfond BS; Shah SK
    JAMA Netw Open; 2020 Jul; 3(7):e209296. PubMed ID: 32735337
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach.
    van der Graaf R; van der Zande ISE; den Ruijter HM; Oudijk MA; van Delden JJM; Oude Rengerink K; Groenwold RHH
    Trials; 2018 Jan; 19(1):78. PubMed ID: 29378652
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The ethics of informed consent.
    Prout TE
    Control Clin Trials; 1981 May; 1(4):429-34. PubMed ID: 7261634
    [TBL] [Abstract][Full Text] [Related]  

  • 75. GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
    Langbaum JB; Karlawish J; Roberts JS; Wood EM; Bradbury A; High N; Walsh TL; Gordon D; Aggarwal R; Davis P; Stowell C; Trisko L; Langlois CM; Reiman EM; Tariot PN
    Alzheimers Dement; 2019 Apr; 15(4):515-524. PubMed ID: 30772251
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patients' perceptions on informed consent and the quality of information disclosure in clinical trials.
    Verheggen FW; Jonkers R; Kok G
    Patient Educ Couns; 1996 Nov; 29(2):137-53. PubMed ID: 9006231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Addressing the ethical challenges of clinical trials that involve patients with dementia.
    Karlawish JH; Casarett D
    J Geriatr Psychiatry Neurol; 2001; 14(4):222-8. PubMed ID: 11794450
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Informed consent: a medical viewpoint.
    Simpson JS
    Med J Aust; 1981 Feb; 1(4):169-71. PubMed ID: 7231277
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Response to the open peer commentaries on "Is there an ethical obligation to disclose controversial risk? A question from the ACCORD Trial".
    DeMarco JP; Ford PJ; Patton DJ; Stewart DO
    Am J Bioeth; 2014; 14(4):W1-2. PubMed ID: 24730505
    [No Abstract]   [Full Text] [Related]  

  • 80. The continuing unethical conduct of underpowered clinical trials.
    Halpern SD; Karlawish JH; Berlin JA
    JAMA; 2002 Jul; 288(3):358-62. PubMed ID: 12117401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.